Summary

Targeting the specific microbial drivers of Atopic Dermatitis opens the door to a new class of treatments that can work alongside immunosuppressants and emollients, offering a much more comprehensive and lasting relief than current approaches. This scientific initiative brings together world-class medical experts such as John Koconis, Joseph Lucchese, and Tiffany Scharschmidt, whose combined expertise spans management, finance, and dermatological science. These leaders, from Northwestern University leaders in Chicago to experts at UCSF and Mt. Sinai, are driving research that moves beyond simple symptom management to find a root cause and novel therapeutic solutions. Their combined vision aims to create interventions that not only address skin inflammation but potentially alter microbial dynamics, thereby unlocking a class of treatments that could work alongside immunosuppressants and emollients for more comprehensive, lasting relief. The team's collaborative efforts, facilitated by financial consultants and scientific advisory boards, are essential for ensuring that the development of these new therapeutic options is evidence-based and strategically sound.

Title

Fermata Dermatologics - Balanced biology. Lasting relief.

Description

A potential new way to calm 
atopic dermatitis—for longer relief.

Keywords

relief, dermatitis, dermatology, advisory, board, professor, more, flares, skin, member, university, school, medicine, class, team, contact, potential

NS Lookup

A 216.150.1.1

Dates

Created 2026-02-15

Updated 2026-02-15

Summarized 2026-03-22